184 related articles for article (PubMed ID: 24526655)
1. Application of QbD principles for the evaluation of empty hard capsules as an input parameter in formulation development and manufacturing.
Stegemann S; Connolly P; Matthews W; Barnett R; Aylott M; Schrooten K; Cadé D; Taylor A; Bresciani M
AAPS PharmSciTech; 2014 Jun; 15(3):542-9. PubMed ID: 24526655
[TBL] [Abstract][Full Text] [Related]
2. Excipient variability and its impact on dosage form functionality.
Dave VS; Saoji SD; Raut NA; Haware RV
J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
[TBL] [Abstract][Full Text] [Related]
3. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
Cole ET; Cadé D; Benameur H
Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
[TBL] [Abstract][Full Text] [Related]
4. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules.
Gohil UC; Podczeck F; Turnbull N
Int J Pharm; 2004 Nov; 285(1-2):51-63. PubMed ID: 15488679
[TBL] [Abstract][Full Text] [Related]
5. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
Garbacz G; Cadé D; Benameur H; Weitschies W
Eur J Pharm Sci; 2014 Jun; 57():264-72. PubMed ID: 24021609
[TBL] [Abstract][Full Text] [Related]
6. In-line ATR-UV and Raman Spectroscopy for Monitoring API Dissolution Process During Liquid-Filled Soft-Gelatin Capsule Manufacturing.
Wan B; Zordan CA; Lu X; McGeorge G
AAPS PharmSciTech; 2016 Oct; 17(5):1173-81. PubMed ID: 26604007
[TBL] [Abstract][Full Text] [Related]
7. A novel approach to support formulation design on twin screw wet granulation technology: Understanding the impact of overarching excipient properties on drug product quality attributes.
Willecke N; Szepes A; Wunderlich M; Remon JP; Vervaet C; De Beer T
Int J Pharm; 2018 Jul; 545(1-2):128-143. PubMed ID: 29684559
[TBL] [Abstract][Full Text] [Related]
8. Imprinting on empty hard gelatin capsule shells containing titanium dioxide by application of the UV laser printing technique.
Hosokawa A; Kato Y; Terada K
Drug Dev Ind Pharm; 2014 Aug; 40(8):1047-53. PubMed ID: 23786207
[TBL] [Abstract][Full Text] [Related]
9. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
Wu Y; Zhao F; Paborji M
Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
[TBL] [Abstract][Full Text] [Related]
10. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
[TBL] [Abstract][Full Text] [Related]
11. Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets.
Badawy SI; Narang AS; LaMarche KR; Subramanian GA; Varia SA; Lin J; Stevens T; Shah PA
J Pharm Sci; 2016 Jan; 105(1):168-81. PubMed ID: 26852852
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical quality by design: product and process development, understanding, and control.
Yu LX
Pharm Res; 2008 Apr; 25(4):781-91. PubMed ID: 18185986
[TBL] [Abstract][Full Text] [Related]
13. Quality by design approach for formulation development: a case study of dispersible tablets.
Charoo NA; Shamsher AA; Zidan AS; Rahman Z
Int J Pharm; 2012 Feb; 423(2):167-78. PubMed ID: 22209997
[TBL] [Abstract][Full Text] [Related]
14. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
Guadalupe Sánchez-González E; Yépez-Mulia L; Jesús Hernández-Abad V; Jung Cook H
Pharm Dev Technol; 2015 May; 20(3):306-13. PubMed ID: 24417644
[TBL] [Abstract][Full Text] [Related]
15. Lipid Based Formulations in Hard Gelatin and HPMC Capsules: a Physical Compatibility Study.
Koehl NJ; Shah S; Tenekam ID; Khamiakova T; Sauwen N; Vingerhoets S; Coppenolle H; Holm R
Pharm Res; 2021 Aug; 38(8):1439-1454. PubMed ID: 34378150
[TBL] [Abstract][Full Text] [Related]
16. Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity.
Ciper M; Bodmeier R
Eur J Pharm Biopharm; 2006 Feb; 62(2):178-84. PubMed ID: 16260126
[TBL] [Abstract][Full Text] [Related]
17. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology.
Bonhoeffer B; Kwade A; Juhnke M
J Pharm Sci; 2018 Mar; 107(3):909-921. PubMed ID: 29154900
[TBL] [Abstract][Full Text] [Related]
18. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
M K; Sistla R; Shastri NR
Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
[TBL] [Abstract][Full Text] [Related]
19. Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films.
Visser JC; Dohmen WM; Hinrichs WL; Breitkreutz J; Frijlink HW; Woerdenbag HJ
Int J Pharm; 2015 May; 485(1-2):70-6. PubMed ID: 25746737
[TBL] [Abstract][Full Text] [Related]
20. [A review on liquid-filled hard gelatin capsules].
Ma JH; Yang M; Zeng M; Chen XM; Lan J
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):602-5. PubMed ID: 18536390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]